Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine on Psychomotor Vigilance and CO2 Tolerance
NCT06636825Completed
- Sponsor
- U.S. Army Research Institute of Environmental Medicine
- Start
- Nov 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hypercapnia comparing Caffeine with Placebo (2 arms). Primary endpoints: End-tidal Carbon Dioxide at 60 minutes, Psychomotor Vigilance Test Performance at 60 minutes and 1 more. Started Nov 2023; status: completed.
02
Drugs
caffeine
03
Conditions
hypercapnia
Beyond the preview
Go deeper on NCT06636825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06636825.